What is the mechanism by which CHC use is associated with an increased risk of venous thromboembolism?...

Question

What is the mechanism by which CHC use is associated with an increased risk of venous thromboembolism?

Accepted Answer

Increased hepatic production of clotting factors, particularly due to the oestrogen component

Answer

Increased platelet aggregation only

Answer

Direct endothelial damage by the progestogen component

Answer

Decreased fibrinolysis caused by the progestogen only

Answer

Reduced antithrombin III caused by the progestogen component

uk-dfsrh MCQ (SBA): CHC VTE Mechanism